Lifeboat Foundation

I’m excited to see Mark O’Connell’s book “To Be a Machine” (about # transhumanism ) get shortlisted for the Royal Society Science Book Prize, one the biggest science book prizes in the world. The final chapter of “To Be a Machine” is about my Immortality Bus journey and presidential campaign (a version of that chapter appeared in The New York Times Magazine after Mark rode with me on the bus). The book also has a wikipedia page now. Winner to be announced on September 19. https://en.m.wikipedia.org/wiki/To_Be_a_Machine

Immensely wealthy and powerful men like Peter Thiel and Elon Musk want to live forever. But at what cost?

One in 10 Elysium customers are doctors. Is ‘Basis’ about to go mainstream?

Good quick interview. Technical, and a mention that it’s not just about telomeres.

BioViva is looking for a way to slow aging. Globalive Chairman Anthony Lacavera talks to CEO Elizabeth Parrish, who is using herself as a test subject and claims to have seen some fascinating results. (Source: Bloomberg)

Futurist José Cordeiro talks longevity, AI, and the humanitarian crisis in Venezuela.

—————

Continue reading “Can Science Reverse Aging?” »

Autophagy means “eating of self” (“auto”= self; “phag” = eating)[1]. Although its name might sound harmful, autophagy appears to have longevity-promoting effects[2]. Here, we will explain what autophagy is, how it works, its benefits, and how it plays a role in aging.

What is Autophagy?

Autophagy is the way cells break down misbehaving or nonfunctional organelles and proteins in the cell[1,2]. This means autophagy can consume organelles such as, mitochondria, peroxisomes, and the endoplasmic reticulum[1].

Antoxerene performs pipeline testing for small molecule drugs that target protein-drug and protein-protein interactions. The platform is based on a patent-pending production technology, which enables manufacturing of impossible to express protein targets in biologically active form, at scale.

The Italian version of Rejuvenaction is up and running! If you know Italian speakers who would like to know about rejuvenation biotechnologies and advocacy, please let them know!

I’m pleased to announce the launch of Rejuvenaction Italia, the Italian version of Rejuvenaction. As you might know, Italian is my native language, and while I have neglected/postponed online advocacy in Italian for over two years now, I realised that, as the topic of rejuvenation starts to reach broader audiences, there’s a necessity to make information available in several languages, for the benefit of those who don’t speak English. Regardless of one’s native language, the questions people have about rejuvenation are always the same: How do you do it? Why? Have you thought of overpopulation? And tyrants living forever? and so on. Thus, Rejuvenaction Italia (henceforth officially nicknamed RJi, and accordingly Rejuvenaction will be simply RJ) is essentially a clone of RJ, except in Italian. The blog won’t be nearly as lively as that here on RJ because, you know, there are only 24 hours in a day. I will translate some of the most substantial posts or important news from RJ to RJi, though, and there will be RJi -specific posts that won’t be worth translating into English.

If you speak Italian and/or know someone who does, it may be worth checking out RJ’s Italian clone and share the news on your social media. I would appreciate that very much. 🙂 There’s a link to RJi at the top of the sidebar.

Continue reading “Introducing Rejuvenaction Italia and other news” »

DUBLIN, August 21, 2017 /PRNewswire/.

The “Regenerative Medicine Market, 2014 — 2025” report has been added to Research and Markets’ offering.

The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to this new report. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.